DrugPatentWatch Database Preview
Array Biopharma Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for ARRAY BIOPHARMA INC, and when can generic versions of ARRAY BIOPHARMA INC drugs launch?
ARRAY BIOPHARMA INC has two approved drugs.
There are twenty US patents protecting ARRAY BIOPHARMA INC drugs.
There are two hundred and eighty-nine patent family members on ARRAY BIOPHARMA INC drugs in fifty-five countries and thirty-two supplementary protection certificates in twelve countries.
Summary for Array Biopharma Inc
| International Patents: | 289 |
| US Patents: | 20 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Array Biopharma Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Array Biopharma Inc | BRAFTOVI | encorafenib | CAPSULE;ORAL | 210496-002 | Jun 27, 2018 | RX | Yes | Yes | 8,501,758 | Start Trial | Y | Y | Start Trial | ||
| Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | RX | Yes | Yes | 9,850,229 | Start Trial | Start Trial | ||||
| Array Biopharma Inc | MEKTOVI | binimetinib | TABLET;ORAL | 210498-001 | Jun 27, 2018 | RX | Yes | Yes | 8,178,693 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Array Biopharma Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 353446 | Start Trial |
| Lithuania | C1482932 | Start Trial |
| Montenegro | 01860 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Array Biopharma Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1482932 | 1990010-9 | Sweden | Start Trial | PRODUCT NAME: BINIMETINIB AND PHARMACEUTICALLY ACCEPTABLE SALTS AND SOLVATES THEROF; REG. NO/DATE: EU/1/18/1315 20180924 |
| 1482932 | 334 8-2019 | Slovakia | Start Trial | PRODUCT NAME: BINIMETINIB VO VSETKYCH FORMACH CHRANENYCH ZAKLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/18/1315 20180924 |
| 1482932 | 300974 | Netherlands | Start Trial | DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGE OF OWNER(S) NAME |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
